big buy order, page-19

There have been many figures bandied around, but one that sticks in my mind is ropren sales being worth $50 million in russia alone within next 2-3 years. lets assume this all goes to the bottom line.

This being the case would set market cap at 1 billion on PE of just 20. Depending on current "actual" market cap, that would put the SP between $5-10.

Now if Ropren gets sold elsewhere, and obviously supply can keep up, SP figure would be multiples of this.

Please correct me or point out anything wrong, my calculations are not dependable! Any way you look at it, SP still a bargin. Time to revise your buy Tharlow...